According to Bright Minds Biosciences latest financial reports the total liabilities of DRUG is $206.29K, an decrease of -81.82% to 2022. At the end of 2022 company had $1.13M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Bright Minds Biosciences is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $206.29K | -81.82% |
2022 | $1.13M | 141.86% |
2021 | $469.04K | 323.11% |
2020 | $110.85K | - |